Alaunos Therapeutics (TCRT) Research & Development (2011 - 2026)
Alaunos Therapeutics (TCRT) reported Research & Development of $427000.0 for Q1 2026, up 23.05% on a YoY basis from $347000.0 in Q1 2025, and up 18.28% quarter-over-quarter from $361000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Research & Development (2011 - 2026) Analysis & Trends
Alaunos Therapeutics has reported Research & Development for 16 years, with the latest figure at $427000.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 23.05% year-over-year to $427000.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 146.92% YoY), and the FY2025 full-year result was $1.4 million, up 276.52% from the prior year.
- Research & Development for Q1 2026 stood at $427000.0, up from $361000.0 in the prior quarter.
- The five-year high for Research & Development was $7.9 million in Q3 2022, with the low at -$86000.0 in Q4 2024.
- Historically, Research & Development has averaged $2.6 million across 5 years, with a median of $469000.0 in 2025.
- Annual changes were most pronounced in 2024 — Research & Development plunged 109.22% — and 2025, when it jumped 519.77%.
- Alaunos Therapeutics' Research & Development stood at $5.6 million in 2022, then tumbled by 83.36% to $933000.0 in 2023, then tumbled by 109.22% to -$86000.0 in 2024, then jumped by 519.77% to $361000.0 in 2025, then rose by 18.28% to $427000.0 in 2026.
- The last three Research & Development figures came in at $427000.0 (Q1 2026), $361000.0 (Q4 2025), and $469000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | 427,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 427,000.00 |
| Dec 31, 2025 | 361,000.00 |
| Sep 30, 2025 | 469,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 347,000.00 |
| Dec 31, 2024 | -86,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 180,000.00 |
| Mar 31, 2024 | 126,000.00 |
| Dec 31, 2023 | 933,000.00 |
| Sep 30, 2023 | 3.66 Mn |
| Jun 30, 2023 | 5.19 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 5.61 Mn |
| Sep 30, 2022 | 7.89 Mn |
| Jun 30, 2022 | 5.94 Mn |
| Mar 31, 2022 | 5.58 Mn |
| Dec 31, 2021 | 8.22 Mn |
| Sep 30, 2021 | 14.52 Mn |
| Jun 30, 2021 | 13.57 Mn |